S N Avdeev, I V Leshchenko, Z R Aisanov, V V Arkhipov, A S Belevskiy, S I Ovcharenko, A V Emelyanov, A I Sinopalnikov, E I Shmelev, A G Chuchalin
Chronic obstructive pulmonary disease is now one of the most common noncommunicable diseases and the main causes of morbidity, disability and mortality in the world. In recent years, new approaches to epidemiology, diagnosis, classification (categorization), evaluation of phenotypes, as well as characterization and assessment of the severity of сhronic obstructive pulmonary disease exacerbations have emerged. Modern approaches to starting and subsequent drug therapy have changed significantly. This is largely due to the results of recently conducted major clinical trials, demonstrated high efficacy of triple fixed combinations, including inhaled glucocorticosteroids, long-acting beta-agonists and long-acting anticholinergic drugs...
April 16, 2024: Terapevticheskiĭ Arkhiv